← Back to Analyst Consensus 
NAGE Buy
Niagen Bioscience, Inc.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 11, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 5, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 31, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 5, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Nov 5, 2025 | Canaccord Genuity | maintain | Buy → Buy | $14 | 48% |
| Aug 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Jun 10, 2025 | Canaccord Genuity | maintain | Buy → Buy | $16 | 48% |
| Jun 6, 2025 | Roth Capital | maintain | Buy → Buy | $23 | 53% |
| May 27, 2025 | Canaccord Genuity | initiate | — → Buy | $13 | 48% |
| Apr 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| Mar 31, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| Mar 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $11 | 44% |
| Mar 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
| Mar 5, 2025 | Ladenburg Thalmann | maintain | Buy → Buy | $8.1 | 45% |
| Nov 6, 2024 | Roth MKM | maintain | Buy → Buy | $8 | 52% |
| Nov 4, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
Price Target Trend
Apr 21, 2026 Latest: $12.08 Oct 22, 2026
EPS Estimates
0y $0.00
Lo: $0.00 Hi: $0.00
1 analysts +1y $-0.06
Lo: $-0.06 Hi: $-0.06
1 analysts +1q $-0.06
Lo: $-0.06 Hi: $-0.06
1 analysts 0q $-0.03
Lo: $-0.03 Hi: $-0.03
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days